An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

By H. Reddel, D. Robin Taylor, E. D. Bateman, L. Boulet, Homer A. Boushey, William W. Busse, Thomas B. Casale, P. Chanez, Paul Enright, Peter G. Gibson and 14 more. American Journal of Respiratory and Critical Care Medicine, 2009

1,757 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/1295c0feed2a74099843c8a9fe64c4ac44e2d32c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

In Pulmonary and Respiratory Medicine

In Sociology and Political Science

Citations in the corpus

Mepolizumab treatment in patients with severe eosinophilic asthma. (2014, neutral): “Worsening of asthma 29 (15) 18 (9) 13 (7)”
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes (2021, positive): “Asthma control is defined as the extent to which the features of asthma are apparent or have been reduced or eliminated by controller treatment (6).”
The COMET Handbook: version 1.0 (2017, background): “The American Thoracic Society/European Respiratory Society employed an expert panel approach [59], whereas other researchers combined results from a Delphi survey with clinicians and interviews with parents and children [60].”
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (2013, methodology): “Page 14 of 112 The definition of Severe Asthma was reviewed with reference to the previous definitions [1, 2, 4, 5] and to more recent definitions [6, 7], and in relation to the definition of asthma control and asthma severity of the ATS/ERS Task Force [8].”